P
IART icon

Pitcairn’s Integra LifeSciences IART Stock Holding History

Pitcairn’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,045
Closed -$290K – 665
2023
Q2 		$290K Sell
7,045
-48
-0.7% -$2.31K 0.02% 520
2023
Q1 		$407K Sell
7,093
-123
-2% -$6.93K 0.04% 402
2022
Q4 		$405K Sell
7,216
-521
-7% -$26.5K 0.04% 366
2022
Q3 		$328K Sell
7,737
-175
-2% -$8.97K 0.04% 391
2022
Q2 		$427K Sell
7,912
-795
-9% -$47.7K 0.05% 341
2022
Q1 		$560K Sell
8,707
-739
-8% -$48.7K 0.05% 323
2021
Q4 		$633K Sell
9,446
-181
-2% -$12.2K 0.04% 310
2021
Q3 		$660K Buy
9,627
+381
+4% +$26.9K 0.05% 274
2021
Q2 		$631K Sell
9,246
-270
-3% -$19.1K 0.04% 277
2021
Q1 		$657K Buy
9,516
+198
+2% +$13.4K 0.05% 261
2020
Q4 		$605K Buy
9,318
+233
+3% +$12.5K 0.05% 254
2020
Q3 		$429K Sell
9,085
-264
-3% -$12.6K 0.04% 275
2020
Q2 		$439K Buy
9,349
+850
+10% +$41.8K 0.04% 248
2020
Q1 		$380K Buy
8,499
+1,730
+26% +$90.8K 0.05% 247
2019
Q4 		$394K Buy
6,769
+193
+3% +$11.5K 0.04% 307
2019
Q3 		$395K Buy
6,576
+175
+3% +$10.4K 0.04% 294
2019
Q2 		$358K Sell
6,401
-754
-11% -$38.8K 0.04% 326
2019
Q1 		$399K Buy
7,155
+2,009
+39% +$102K 0.04% 266
2018
Q4 		$232K Sell
5,146
-652
-11% -$35.8K 0.03% 375
2018
Q3 		$382K Sell
5,798
-362
-6% -$22.5K 0.04% 323
2018
Q2 		$396K Buy
6,160
+61
+1% +$3.78K 0.04% 303
2018
Q1 		$338K Buy
+6,099
New +$320K 0.04% 344
2017
Q3 		– Sell
-3,783
Closed -$207K – 497
2017
Q2 		$207K Buy
+3,783
New +$181K 0.02% 440

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pitcairn's IART Position: Q3 2023 in Review

Pitcairn sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 7,045 shares — an estimated $290K sold.

Pitcairn first reported a position in IART in Q2 2017 and held it in 23 quarters. The position peaked at $660K in Q3 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Pitcairn reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Pitcairn sold 7,045 Integra LifeSciences shares in Q3 2023, an estimated $290K.
  • Pitcairn first reported a position in Integra LifeSciences in Q2 2017 and held it in 23 quarters.
  • Pitcairn's Integra LifeSciences position peaked at $660K in Q3 2021.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Pitcairn's 13F filing for Q3 2023, filed 13 Nov 2023.